Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA, posted on X about recent paper by Lisa M. Brown et al., titled “Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer” published on Annals of Thoracic Surgery.
Authors: Lisa M. Brown, Levi Bonnell, Niharika Parsons, David T. Cooke, Luis A. Godoy, Elizabeth A. David, Paul Schipper, Thomas K. Varghese, Jr., Robert Habib, Brian Mitzman
“New data demonstrate 8% of patients undergoing lobectomy at STS reporting sites were discharged with supplemental oxygen from 2018-2021. At 30 days, slightly more than 3% remained on supplemental oxygen.”
Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university. He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023